24.18
24.18 (0%)
As of Feb 14, 2025
Integra Lifesciences Holdings Corp [IART]
Source:
Company Overview
Integra Lifesciences Holdings Corp currently manufacture and sell our medical technologies and products in the following two reportable business segments: Codman Specialty Surgical and Tissue Technologies.
| Country | United States |
| Headquarters | princeton, new jersey |
| Phone Number | 6092750500 |
| Industry | manufacturing |
| CEO | Integra Lifesciences Holdings Corp |
| Website | https://www.integralife.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $1,610.5 |
| Operating Profit | $28.4 |
| Net Income | $-6.9 |
| Net Cash | $-30 |
Profit Ratios
| Gross Margin | $882.1 |
| Operating Margin | 1.8 |
| Profit as % of Revenues | -12,702.5% |
| Profit as % of Assets | -0.2% |
| Profit as % of Stockholder Equity | -0.5% |
Management Effectiveness
| Return on Equity | -0.5% |
| Return on Assets | -0.2% |
| Turnover Ratio | 41.2% |
| EBITA | $49.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $4,037.4 |
| Total Liabilities | $2,492.1 |
| Operating Cash Flow | $129.4 |
| Investing Cash Flow | $-390.8 |
| Financing Cash Flow | $237.9 |
